Early prediction of thyroid capsule invasion in papillary microcarcinoma using ultrasound-based deep learning models: a retrospective multicenter study.
Authors
Affiliations (25)
Affiliations (25)
- Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
- Center of Intelligent Diagnosis and Therapy (Taizhou), Hangzhou Institute of Medicine(HIM), Chinese Academy of Sciences, Taizhou, China.
- Wenling Institute of Big Data and Artificial Intelligence in Medicine, Taizhou, China.
- Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, China.
- Research Center of Interventional Medicine and Engineering, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
- Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.
- Cancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, China.
- Department of Ultrasound, The First Hospital of Jiaxing & The Affiliated Hospitalof Jiaxing University, Jiaxing, China.
- Center of Minimally Invasive Treatment for Tumor, Department of Medical Ultrasound, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
- Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment, National Clinical Research Center for Interventional Medicine, Shanghai, China.
- Jinhua People's Hospital, Jinhua, China.
- Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. [email protected].
- Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. [email protected].
- Center of Intelligent Diagnosis and Therapy (Taizhou), Hangzhou Institute of Medicine(HIM), Chinese Academy of Sciences, Taizhou, China. [email protected].
- Wenling Institute of Big Data and Artificial Intelligence in Medicine, Taizhou, China. [email protected].
- Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, China. [email protected].
- Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. [email protected].
- Center of Intelligent Diagnosis and Therapy (Taizhou), Hangzhou Institute of Medicine(HIM), Chinese Academy of Sciences, Taizhou, China. [email protected].
- Wenling Institute of Big Data and Artificial Intelligence in Medicine, Taizhou, China. [email protected].
- Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, China. [email protected].
- Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. [email protected].
- Wenling Institute of Big Data and Artificial Intelligence in Medicine, Taizhou, China. [email protected].
- Research Center of Interventional Medicine and Engineering, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. [email protected].
- Center of Minimally Invasive Treatment for Tumor, Department of Medical Ultrasound, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. [email protected].
- Wenzhou Medical University, Wenzhou, China. [email protected].
Abstract
Thyroid capsule invasion (TCI) predicts early progression in papillary thyroid microcarcinoma (PTMC). This study aimed to develop an integrated model that combines handcrafted peri-tumoral radiomics features with deep learning (DL)-derived intra-tumoral features for accurate early prediction of TCI, to support clinical decision-making. Retrospective data from 964 patients with 964 pathologically confirmed PTMC lesions across three centers were collected. Radiomics features were extracted from multiple peri-tumoral regions, and the optimal peri-tumor region with the best radiomics features was selected using a support vector machine (SVM). The selected radiomics features were then combined with intra-tumoral DL features extracted from the tumors before being fed into four different DL models for training and validation. Performance was validated on the internal (n = 177) and external (n = 84) test sets. Six radiologists (senior/attending/junior) assessed TCI with/without DL assistance. The radiomics features, which achieved the best diagnostic performance with an AUC of 0.795 using SVM, were extracted from the peri-tumor region with 30% expansion from the original tumor. By further combining these radiomics features with intra-tumoral DL features, four different DL models were established to identify TCI in PTMC. Swin-Transformer achieved superior performance (internal AUC: 0.923; external AUC: 0.892). With DL model assistance, the AUCs of six radiologists significantly improved, for example, from 0.720 to 0.796 and from 0.725 to 0.790 for senior radiologists, and similar gains were observed for attending and junior radiologists. As an effective clinical assistive tool, this integrated model can provide TCI identification with high level of accuracy. With its ability to enhance radiologists' diagnostic performance, it supports early PTMC risk stratification and personalized intervention. This retrospective multicenter study establishes an integrated model for identifying TCI in PTMC. The model significantly enhances radiologists' diagnostic precision across multiple experience levels, supporting early clinical decision-making for optimized intervention strategies. Accurate prediction of TCI facilitates early assessment of PTMC progression and guides subsequent individualized clinical management. DL significantly improves the predictive performance for TCI. DL effectively assists radiologists in TCI diagnosis.